Results 201 to 210 of about 331,968 (290)

“The Awakening Has Come”: Canadian First Nations in the Great War Era, 1914-1932 [PDF]

, 2015
Eric Story
core   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

1925-2025: a century of international pharmaceutical law. [PDF]

J Pharm Policy Pract
Riboulet-Zemouli K.
europepmc   +1 more source

Legitimasing cartels. The joint roles of the League of Nations and of the International Chamber of Commerce [PDF]

, 2016
Bertilorenzi, Marco
core  

Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme

British Journal of Clinical Pharmacology, EarlyView.
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang, Ana Soldo, Olgica Velkovski Škopić, Sunčana Vlah Tomičević, Tin Šaban, Andrej Belančić, Ana Jelaković, Josipa Josipović, Mihaela Marinović Glavić, Ivan Pećin, Luka Prgomet, Tajana Željković Vrkić, Bojan Jelaković   +12 more
wiley   +1 more source

Challenges and Solutions to Supporting Physical Literacy within Youth Sport. [PDF]

Sports Med
Till K, Lara-Bercial S, Baker J, Morley D.   +3 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Youth washing as a corporate social responsibility tactic of health-harming industries. [PDF]

Health Promot Int
Witchalls S, Pitt H, McCarthy S, Freeman B, Thomas S.   +4 more
europepmc   +1 more source

Public health, primary healthcare, and "corporatization" of health. [PDF]

J Family Med Prim Care
Bhattacharya J.
europepmc   +1 more source